A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia [13]

Leukemia

Volumn 21, Issue 4, 2007, Pages 833-835

  van der Velden, V H J ^a   Beverloo, H B ^a   Hoogeveen, P G ^a   Zwaan, Ch M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BREAKPOINT CLUSTER REGION PROTEIN; HYDROXYUREA; IMATINIB;

BASE PAIRING; BLOOD CELL COUNT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; DNA SEQUENCE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DELETION; GENE FUSION; GENE INSERTION; GENETIC TRANSCRIPTION; HUMAN; KARYOTYPING; LETTER; LEUKAPHERESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA; WESTERN BLOTTING;

EID: 33947358675     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404580     Document Type: Letter

References (8)

1. Barnes DJ, Melo JV. Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia. Acta Haematol 2002; 108: 180-202.
2. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
3. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V., Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-1928.
4. Boeckx N, Jansen MW, Haskovec C, Vandenberghe P, van der Velden VH, van Dongen JJ. Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR. Leukemia 2005; 19: 1292-1295.
5. Moreno Model P, Cortinas MN, Bonomi R, Cardeza A, Uriarte Mdel R. A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypical chronic myeloproliferative syndrome. Blood 2001; 97: 3668-3669.
6. Byrne JL, Carter GI, Davies JM, Haynes AP, Russell NH, Cross NC. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course. Br J Haematol 1998; 103: 791-794.
7. Demehri S, Paschka P, Schultheis B, Lange T, Koizumi T, Sugimoto T et al. e8a2 BCR-ABL: More frequent than other atypical BCR-ABL variants? Leukemia 2005; 19: 681-684.
8. Roman J, Parziale A, Gottardi E, De Micheli D, Cilloni D, Tiribelli M et al. Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation. Br J Haematol 2000; 111: 644-646.